Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,507	368	86	116	20	44
Market Cap Growth	573.60%	330.28%	-26.01%	472.04%	-54.55%	-33.49%
Enterprise Value	1,263	304	-2	1	6	5
Last Close Price	11.36	4.12	1.34	1.93	0.78	2.42
PB Ratio	7.67	3.70	1.04	1.08	1.18	1.63
P/TBV Ratio	7.68	3.70	1.04	1.08	1.18	1.63
Debt / Equity Ratio	0.00	0.01	0.02	0.09	0.86	0.52
Quick Ratio	21.69	10.29	14.33	8.99	2.90	8.10
Current Ratio	21.93	10.41	15.03	9.15	2.98	8.33
Return on Equity (ROE)	-36.87%	-52.59%	-30.59%	-46.82%	-153.03%	-80.07%
Return on Assets (ROA)	-23.93%	-32.15%	-19.96%	-23.15%	-47.42%	-37.91%
Return on Capital (ROIC)	-25.61%	-34.90%	-21.15%	-25.18%	-55.37%	-42.13%
Return on Capital Employed (ROCE)	-27.00%	-51.30%	-40.60%	-27.30%	-126.10%	-78.10%
Earnings Yield	-3.15%	-13.01%	-33.97%	-25.21%	-167.88%	-73.64%
FCF Yield	-3.02%	-10.40%	-37.22%	-24.50%	-143.18%	-65.27%
Buyback Yield / Dilution	-24.43%	-2.97%	-53.44%	-182.56%	-26.48%	-53.88%

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q